FDA Import Refusal 1FX-3151722-9/20002/3 — THE HIMALAYA DRUG COMPANY
The FDA refused shipment 1FX-3151722-9/20002/3 from THE HIMALAYA DRUG COMPANY (India) on Apr 17, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 17, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VDA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,75